Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study.
de Nigris E, Treharne C, Brighton N, Holmgren U, Walker A, Haughney J. de Nigris E, et al. Among authors: walker a. Int J Chron Obstruct Pulmon Dis. 2022 Nov 22;17:2987-3000. doi: 10.2147/COPD.S381138. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36444374 Free PMC article.
Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England.
Lee D, Amadi A, Sabater J, Ellis J, Johnson H, Kotapati S, McNamara S, Walker A, Cooper M, Patterson K, Roskell N, Meng Y. Lee D, et al. Among authors: walker a. Pharmacoecon Open. 2019 Mar;3(1):43-54. doi: 10.1007/s41669-018-0080-5. Pharmacoecon Open. 2019. PMID: 29790020 Free PMC article.
The cost effectiveness of larval therapy in venous ulcers.
Wayman J, Nirojogi V, Walker A, Sowinski A, Walker MA. Wayman J, et al. Among authors: walker a, walker ma. J Tissue Viability. 2000 Jul;10(3):91-4. doi: 10.1016/s0965-206x(00)80036-4. J Tissue Viability. 2000. PMID: 11299572 Clinical Trial.
Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England.
Lee D, Amadi A, Sabater J, Ellis J, Johnson H, Kotapati S, McNamara S, Walker A, Cooper M, Patterson K, Roskell N, Meng Y. Lee D, et al. Among authors: walker a. Pharmacoecon Open. 2019 Mar;3(1):127. doi: 10.1007/s41669-018-0096-x. Pharmacoecon Open. 2019. PMID: 30206825 Free PMC article.
6,151 results